Investor AB and EQT has agreed to sell Gambro Health Care to Bridgepoint for an undisclosed sum from Gambro Holding AB. Prior to the sale EQT has held a 51% stake in the company, and Investor AB held the remaining. The sale of Gambro Healthcare is part of the value creation plan which has been implemented since Investor AB and EQT acquired the Gambro Holding AB in June 2006. The divestiture of the clinics will allow greater focus on driving further value creation in Gambro Renal Products as well as Gambro BCT, while Gambro Healthcare can accelerate its development with the new owner.
Glass Container companies are portfolio companies of Horizon Capital’s Western NIS Enterprise Fund
Seed investor Heartbeat Labs will retain a 10% stake in Fernarzt
Innovery is a portfolio company of Wisequity IV, which closed on €215m and is currently 92% deployed
Fund will be larger than its predecessor, which closed on €280m in July 2018